Researchers have found a substitute for insulin to help treat diabetes orally, replacing painful pricks. Over 10 years, Erik Helmerhorst, professor at Curtin University, and colleagues looked at three million compounds on pharmaceutical databases to try to emulate the molecular map of insulin. They found one, and are developing it to 'take the needle out of diabetes'. "Our innovation is the development of a new chemical entity, a small drug molecule we have discovered and developed, that can be taken orally as a tablet to replace insulin per se," said Helmerhorst. The research has the ability to revolutionise the treatment of diabetes, which is a growing problem worldwide. Helmerhorst said there was a niche market for their drug molecule to target Type 2 diabetics to help delay the onset of insulin dependency, according to a Curtin statement. He said 95 percent of diabetics have Type 2 diabetes; they last year spent some $10 billion on insulin. "The reality is that nearly one-third of Type 2 diabetics will end up needing insulin therapy at some stage," he said. According to the scientist, the insulin substitute would appeal to people who were averse to taking insulin via injections or by pumps. Helmerhorst outlined his team's quest at the Univation 2011 conference in Perth Nov 2-3.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor